Skip to main content
. Author manuscript; available in PMC: 2023 Nov 7.
Published in final edited form as: Mol Pharm. 2022 Oct 21;19(11):4320–4332. doi: 10.1021/acs.molpharmaceut.2c00662

Table 1.

OATP1B1 Inhibition (20μM); 20% Threshold had 77 ‘active’ and 399 ‘inactive’ compounds. Values represent 5-fold nested cross validation averages (*DL = 20% hold-out set). The rank normalized score is a normalized average of each of these metrics.

Method
Name
AUC F1-
Score
ACC Recall Specificity Precision Cohen's
Kappa
MCC   Rank
Normalized
Score
ada 0.71 0.07 0.84 0.04 1.00 0.40 0.05 0.10 0.52
bnb 0.81 0.34 0.85 0.26 0.97 0.67 0.28 0.33 0.65
DL* 0.74 0.42 0.85 0.31 0.96 0.63 0.34 0.37 0.66
knn 0.73 0.40 0.86 0.30 0.97 0.64 0.33 0.37 0.65
lreg 0.77 0.36 0.85 0.27 0.96 0.65 0.29 0.34 0.65
rf 0.79 0.41 0.86 0.30 0.97 0.69 0.34 0.38 0.67
svc 0.80 0.41 0.63 0.81 0.59 0.28 0.23 0.30 0.60
xgb 0.78 0.37 0.85 0.29 0.95 0.55 0.29 0.31 0.64